In this issue of the JCI, Garrigue, Kermasson, and colleagues demonstrate that human oncostatin M (OSM) deficiency underlies profound anemia, thrombocytopenia, and neutropenia, unraveling another inherited bone marrow failure syndrome (IBMFS) (1). This evidence concerns the gene OSM and hyperinsulinemic hypoglycemia, familial, 4.